People · Operator
Named in public records as an officer, director or promoter · active 2019–2024 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Virica Biotech Inc. | — | Biotechnology | Seed | $7.0M | $18.5M | 2024 |
| Sonnet Biotherapeutics, Inc. | — | Pharmaceuticals | Pre-Seed | $750K | $35.5M | 2019 |
Susan Dexter at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Susan Dexter on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daniella Kranjac | 1 | 4 |
| Pankaj Mohan | 1 | 3 |
| Donald Griffith | 1 | 2 |
| Ken Newport | 1 | 1 |
| John Cini | 1 | 1 |
| Terence Rugg | 1 | 1 |
| Jean-Simon Dr. Diallo | 1 | 1 |
| Ella Korets-Smith | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.